将脂肪性肝病从非酒精性脂肪性肝病重新定义为代谢功能障碍相关脂肪性肝病提高了疾病认知度：墨西哥的经验。 - Suppr

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience.

作者信息

Méndez-Sánchez Nahum, Díaz-Orozco Luis, Córdova-Gallardo Jacqueline

机构信息

Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico; National Autonomous University of Mexico, Mexico City, Mexico.

出版信息

J Hepatol. 2021 Jul;75(1):221-222. doi: 10.1016/j.jhep.2021.04.021. Epub 2021 Apr 20.

DOI:10.1016/j.jhep.2021.04.021

PMID:33892008

Abstract

摘要

相似文献

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience.

J Hepatol. 2021 Jul;75(1):221-222. doi: 10.1016/j.jhep.2021.04.021. Epub 2021 Apr 20.

Hepatologists' Awareness and Knowledge of NAFLD and the Familiarity with Renaming NAFLD to MAFLD.

Endocr Metab Immune Disord Drug Targets. 2024;24(12):1445-1453. doi: 10.2174/1871530323666221028154159.

NAFLD, MAFLD and DAFLD.

Dig Liver Dis. 2020 Dec;52(12):1519-1520. doi: 10.1016/j.dld.2020.09.013. Epub 2020 Oct 2.

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease.

Lancet Gastroenterol Hepatol. 2021 Jan;6(1):65-72. doi: 10.1016/S2468-1253(20)30340-X. Epub 2020 Nov 9.

Redefining fatty liver disease: an international patient perspective.

Lancet Gastroenterol Hepatol. 2021 Jan;6(1):73-79. doi: 10.1016/S2468-1253(20)30294-6. Epub 2020 Oct 5.

Comparison of MAFLD and NAFLD diagnostic criteria in real world.

Liver Int. 2020 Sep;40(9):2082-2089. doi: 10.1111/liv.14548. Epub 2020 Jul 26.

Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study.

Int J Environ Res Public Health. 2021 Aug 26;18(17):8993. doi: 10.3390/ijerph18178993.

A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.

J Hepatol. 2020 Jan;72(1):14-24. doi: 10.1016/j.jhep.2019.08.027. Epub 2019 Sep 10.

The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD.

J Hepatol. 2021 May;74(5):1256-1258. doi: 10.1016/j.jhep.2021.01.015. Epub 2021 Jan 20.

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.

Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.

引用本文的文献

Two years on, a perspective on MAFLD.

eGastroenterology. 2023 Sep 11;1(2):e100019. doi: 10.1136/egastro-2023-100019. eCollection 2023 Sep.

Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma.

Medicina (Kaunas). 2025 Jan 7;61(1):88. doi: 10.3390/medicina61010088.

Impact of metabolic-associated fatty liver disease on the cholesterol efflux capacity of high-density lipoproteins in adolescents with type 2 diabetes.

Front Pediatr. 2024 Dec 24;12:1462406. doi: 10.3389/fped.2024.1462406. eCollection 2024.

An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease.

Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):386-403. doi: 10.21037/hbsn-22-421. Epub 2023 Feb 23.

The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease.

Ther Adv Endocrinol Metab. 2023 Jun 5;14:20420188231178370. doi: 10.1177/20420188231178370. eCollection 2023.

Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate.

World J Hepatol. 2023 Feb 27;15(2):123-128. doi: 10.4254/wjh.v15.i2.123.

NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care.

Intern Emerg Med. 2023 Jun;18(4):993-1006. doi: 10.1007/s11739-023-03203-0. Epub 2023 Feb 17.

Cirrhosis etiology trends in developing countries: Transition from infectious to metabolic conditions. Report from a multicentric cohort in central Mexico.

Lancet Reg Health Am. 2021 Dec 21;7:100151. doi: 10.1016/j.lana.2021.100151. eCollection 2022 Mar.

MAFLD: what 2 years of the redefinition of fatty liver disease has taught us.

Ther Adv Endocrinol Metab. 2022 Nov 22;13:20420188221139101. doi: 10.1177/20420188221139101. eCollection 2022.

The NAFLD-MAFLD debate through the lens of the Arab world.

Saudi J Gastroenterol. 2022 Nov-Dec;28(6):413-416. doi: 10.4103/sjg.sjg_314_22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience.

J Hepatol. 2021 Jul;75(1):221-222. doi: 10.1016/j.jhep.2021.04.021. Epub 2021 Apr 20.

Hepatologists' Awareness and Knowledge of NAFLD and the Familiarity with Renaming NAFLD to MAFLD.

Endocr Metab Immune Disord Drug Targets. 2024;24(12):1445-1453. doi: 10.2174/1871530323666221028154159.

NAFLD, MAFLD and DAFLD.

Dig Liver Dis. 2020 Dec;52(12):1519-1520. doi: 10.1016/j.dld.2020.09.013. Epub 2020 Oct 2.

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease.

Lancet Gastroenterol Hepatol. 2021 Jan;6(1):65-72. doi: 10.1016/S2468-1253(20)30340-X. Epub 2020 Nov 9.

Redefining fatty liver disease: an international patient perspective.

Lancet Gastroenterol Hepatol. 2021 Jan;6(1):73-79. doi: 10.1016/S2468-1253(20)30294-6. Epub 2020 Oct 5.

Comparison of MAFLD and NAFLD diagnostic criteria in real world.

Liver Int. 2020 Sep;40(9):2082-2089. doi: 10.1111/liv.14548. Epub 2020 Jul 26.

Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study.

Int J Environ Res Public Health. 2021 Aug 26;18(17):8993. doi: 10.3390/ijerph18178993.

A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.

J Hepatol. 2020 Jan;72(1):14-24. doi: 10.1016/j.jhep.2019.08.027. Epub 2019 Sep 10.

The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD.

J Hepatol. 2021 May;74(5):1256-1258. doi: 10.1016/j.jhep.2021.01.015. Epub 2021 Jan 20.

MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.

Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8.

引用本文的文献

Two years on, a perspective on MAFLD.

eGastroenterology. 2023 Sep 11;1(2):e100019. doi: 10.1136/egastro-2023-100019. eCollection 2023 Sep.

Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma.

Medicina (Kaunas). 2025 Jan 7;61(1):88. doi: 10.3390/medicina61010088.

Impact of metabolic-associated fatty liver disease on the cholesterol efflux capacity of high-density lipoproteins in adolescents with type 2 diabetes.

Front Pediatr. 2024 Dec 24;12:1462406. doi: 10.3389/fped.2024.1462406. eCollection 2024.

An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease.

Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):386-403. doi: 10.21037/hbsn-22-421. Epub 2023 Feb 23.

The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease.

Ther Adv Endocrinol Metab. 2023 Jun 5;14:20420188231178370. doi: 10.1177/20420188231178370. eCollection 2023.

Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate.

World J Hepatol. 2023 Feb 27;15(2):123-128. doi: 10.4254/wjh.v15.i2.123.

NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care.

Intern Emerg Med. 2023 Jun;18(4):993-1006. doi: 10.1007/s11739-023-03203-0. Epub 2023 Feb 17.

Cirrhosis etiology trends in developing countries: Transition from infectious to metabolic conditions. Report from a multicentric cohort in central Mexico.

Lancet Reg Health Am. 2021 Dec 21;7:100151. doi: 10.1016/j.lana.2021.100151. eCollection 2022 Mar.

MAFLD: what 2 years of the redefinition of fatty liver disease has taught us.

Ther Adv Endocrinol Metab. 2022 Nov 22;13:20420188221139101. doi: 10.1177/20420188221139101. eCollection 2022.

The NAFLD-MAFLD debate through the lens of the Arab world.

Saudi J Gastroenterol. 2022 Nov-Dec;28(6):413-416. doi: 10.4103/sjg.sjg_314_22.

Redefinition of fatty liver disease from NAFLD to MAFLD raised disease awareness: Mexican experience.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献